Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2009-11-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to compare iron absorption in apparently healthy children aged 3-6y from an instant full cream milk drink fortified with ferric pyrophosphate or ferric ammonium phosphate relative to ferrous sulfate as the reference fortificant.
* To compare iron absorption from ferric pyrophosphate to ferric ammonium phosphate from the milk drink
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Iron Bioavailability From Dairy Product
NCT02585661
Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk
NCT02254460
Iron Bioavailability of Fortified Oat Drink
NCT01423162
Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents
NCT03703739
Nutrient and Immunity Status in Children Aged 3-5 Years Consuming Their Habitual Diet With or Without Fortified Milk
NCT05440604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Comparison of iron absorption from FAP to Ferrous sulfate in milk
Iron fortified milk with iron salt labelled with 58Fe and 57Fe
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast. The alternate test drink was fed on the following day in the same fashion. The administration was repeated on day 3 and 4.
2
Comparison of iron absorption from ferric pyrophosphate to Ferrous sulfate in milk
Iron fortified milk with iron salt labelled with 58Fe and 57Fe
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast. The alternate test drink was fed on the following day in the same fashion. The administration was repeated on day 3 and 4.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iron fortified milk with iron salt labelled with 58Fe and 57Fe
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast. The alternate test drink was fed on the following day in the same fashion. The administration was repeated on day 3 and 4.
Iron fortified milk with iron salt labelled with 58Fe and 57Fe
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast. The alternate test drink was fed on the following day in the same fashion. The administration was repeated on day 3 and 4.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal BMI for age (WHO standard)
* Apparently healthy, no metabolic or gastrointestinal disorder
* Non-anemic (WHO cut-off for respective age
* No medication or vitamin/mineral supplements will be consumed during the study
* Intake of Vitamin/mineral supplements will be discontinued 2 weeks before the start of the study
* Parents demonstrate an understanding of the given information and ability to comply with the study procedure
* Having obtained his/her parents or his/her legal representative's informed consent
Exclusion Criteria
* Possible to have medication during the study
* Currently participating or having participated another clinical trial during the past 3 months prior the beginning of this study
* Subject who cannot be expected to comply with treatment
3 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ETH Zurich (Switzerland)
OTHER
Food and Nutrition Research Institute, Philippines
OTHER_GOV
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
References
Explore related publications, articles, or registry entries linked to this study.
Walczyk T, Kastenmayer P, Storcksdieck Genannt Bonsmann S, Zeder C, Grathwohl D, Hurrell RF. Ferrous ammonium phosphate (FeNH(4)PO(4)) as a new food fortificant: iron bioavailability compared to ferrous sulfate and ferric pyrophosphate from an instant milk drink. Eur J Nutr. 2013 Jun;52(4):1361-8. doi: 10.1007/s00394-012-0445-y. Epub 2012 Sep 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09.07NRC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.